Navigation Links
Oppenheimer Announces the Addition of Several Recent Senior Hires in Investment Banking
Date:3/17/2009

NEW YORK, March 17 /PRNewswire/ -- Oppenheimer & Co. Inc., a unit of Oppenheimer Holdings Inc., is pleased to announce the addition of several recent senior hires in the Investment Banking Department.

Brian A. McCarthy has joined the firm as the Head of our Healthcare Investment Banking Group. Brian has more than 20 years of investment banking experience and most recently served as Co-head of Global Healthcare at JPMorgan. Prior to JPM, Brian spent seven years at Lehman Brothers where he was also Co-head of Healthcare. Brian has extensive experience in multiple healthcare subsectors and a proven track record of serving as a trusted advisor to his clients. Brian will report to Marshall A. Heinberg, Senior Managing Director and Head of Investment Banking at Oppenheimer.

Joining Brian as a Managing Director in Healthcare is Jaime Burnes. Jaime most recently was a member of the Healthcare Group at Credit Suisse. Jaime had been with Credit Suisse since 2006, generating and executing financing and M&A transactions in the biotechnology and specialty pharmaceutical sectors. Prior to working at Credit Suisse, Jaime worked for Lehman Brothers. At Oppenheimer, Jaime will continue his focus on the life sciences space.

Also joining the firm as a Director in Healthcare is Eric Rabinowitz. Eric joins Oppenheimer from JPMorgan (and before that Bear Stearns) where he was a Vice President in the Healthcare Group. Eric had been with Bear Stearns since 2003 advising clients and executing transactions across multiple healthcare subsectors. At Oppenheimer, Eric will focus on the healthcare services space.

David Sommer has joined our Financial Sponsors Group as a Managing Director. David has approximately fifteen years of investment banking experience and most recently was a Managing Director in the Financial Sponsor Group at JPMorgan. Prior to JPM, David spent nine years at CIBC World Markets Corp. where he was a Managing Director in the Financial Sponsor/Leveraged Finance Group. David has also worked in the Leveraged Finance Group at JPMorgan and at the General Electric Company in Corporate Business Development. David has a proven track record of generating equity, M&A, and leveraged finance business with financial sponsors and their portfolio companies.

Jeffrey Berson has joined our Technology and Telecom Group as a Managing Director. Jeff joins us from Barclays Capital where he was a Managing Director in the Telecom Group. Jeff had been with Barclays since 2007 focusing on the Wireline, Wireless and Emerging Telecom sectors. Prior to working at Barclays, Jeff worked for CIBC World Markets in the Technology & Telecom Group. At Oppenheimer, Jeff will continue his coverage of growth companies in both the wireline and wireless sectors.

"We are delighted to be able to recruit such an outstanding roster of high quality professionals to our firm," noted Marshall Heinberg. "Each of these individuals are proven bankers who are well positioned to serve their clients at Oppenheimer. We have witnessed a tremendous opportunity to recruit seasoned bankers who are well versed in delivering a full suite of banking products to our middle market clients."

Oppenheimer & Co. Inc. (Oppenheimer), a principal subsidiary of Oppenheimer Holdings Inc. (OPY on the New York Stock Exchange), and its affiliates provide a full range of wealth management, securities brokerage and investment banking services to high-net-worth individuals, families, corporate executives, local governments, businesses and institutions.

Certain statements in this release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially, as discussed in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Oppenheimer & Co. Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PAREXEL International to Present at Oppenheimer 19th Annual Healthcare Conference
2. Novavax CEO to Present at Oppenheimer 19th Annual Healthcare Conference
3. Rosetta Genomics to Present at Oppenheimers 19th Annual Healthcare Conference
4. Arena Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference
5. AEterna Zentaris to Present at Upcoming Oppenheimer 19th Annual Healthcare Conference
6. Neurocrine Biosciences to Present at the Oppenheimer 19th Annual Healthcare Conference
7. Beckman Coulter to Present at the Oppenheimer Annual Healthcare Conference
8. 3SBio Inc. to Present at The Oppenheimer 2nd Annual China Dragon Call Conference
9. AspenBio Pharma to Present at the Oppenheimer Best Ideas 1x1 Conference
10. Novavax Announces Release Date of 2008 Fourth Quarter Financial Results and Investor Conference Call
11. Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Mass. , March 23, 2017 /PRNewswire/ ... partner to global in vitro diagnostics manufacturers ... of the industry,s first multiplexed Inherited ... disease testing by next-generation sequencing (NGS). The ... were developed with input from industry experts ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... was recently selected by the Connecticut Technology Council (CTC) as a 2017 Women ... CTC’s thirteenth annual Women of Innovation Awards Dinner. , The dinner recognizes women ...
(Date:3/23/2017)... , March 23, 2017 According to ... products and derivatives market is fragmented due to the presence of a ... as Proliant, Thermo Fisher , and Sigma-Aldrich, compete with each ... three companies, collectively, held more than 76% of this market in ... As of ...
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced Polymer Monitoring Technologies (APMT), ... Sigmund “Sig” Floyd as Vice President ? Global Business Development. Dr. Floyd will ... “Dr. Floyd’s career has spanned 30 years in the chemicals and equipment industries. ...
Breaking Biology Technology:
(Date:2/28/2017)... , Spanien, 27. Februar 2017  EyeLock LLC, ein ... wird seine erstklassige biometrische Lösung zur Iris-Erkennung ... mit X16 LTE auf dem Mobile World ... am Qualcomm-Stand in Halle 3, Stand 3E10, ... die Sicherheitsplattform Qualcomm Haven™ – eine Kombination ...
(Date:2/24/2017)... , Feb. 24, 2017  EyeLock LLC, a leader ... its elite iris biometric solution on the latest ... LTE at Mobile World Congress 2017 (February ... Booth in Hall 3, Stand 3E10. ... Qualcomm Haven™ security platform—a combination of hardware, ...
(Date:2/21/2017)... -- Der weltweite Biobanking-Sektor wird bis zum ... mit mehr als 50 Vertretern aus verschiedenen Branchen wurde aber ... diese Prognose zu realisieren. ... Zu den Schwierigkeiten für ... für die Biobank, die Implementierung Zeit sparender Technologien, ein ...
Breaking Biology News(10 mins):